Please login to the form below

Not currently logged in

liver damage

This page shows the latest liver damage news and features for those working in and with pharma, biotech and healthcare.

Nektar’s opioid analgesic slammed with FDA panel rejection

Nektar’s opioid analgesic slammed with FDA panel rejection

The panel also wanted to know if liver damage could occur at the higher doses of the drug, but a clinical study of NKTR-181 contained too few patients at the ... higher dose of 600mg twice daily to determine if this dose would lead to liver damage.

Latest news

More from news
Approximately 1 fully matching, plus 55 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...